Blontuvetmab

Blontuvetmab (AT 004) is a caninized CD20 monoclonal antibody and can be used for the research of Canine B-cell lymphoma[1][2].

Product Specifications

CAS Number

[1608112-78-2]

Product Name Alternative

AT 004; VT 007

UNSPSC

12352203

Target

CD20

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/blontuvetmab.html

Purity

99.08

Solubility

H2O

Smiles

[Blontuvetmab]

Molecular Weight

(145.04 kDa)

References & Citations

[1]Mizuno T, et, al. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Sci Rep. 2020 Jul 10;10 (1) :11476. |[2]Dias JNR, et al. Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy. Sci Rep. 2022 Feb 17;12 (1) :2678.